Welcome to the OMA Blog
The Obesity Medicine Association Blog is the leading industry hub for obesity medicine. Find the latest research, expert insights, and practical tips to tackle the multifaceted disease of obesity. Hear from OMA Outreach Committee members, OMA Board members, and more to gain a deeper understanding of the complex factors influencing obesity and explore innovative approaches to prevention, treatment, and long-term management. Join a community of healthcare professionals, researchers, and individuals passionate about combating obesity.
View by Category
The Obesity-CVD Connection: Understanding Risks and Treatment Strategies
Obesity is a major risk factor for cardiovascular disease (CVD), contributing to hypertension, dyslipidemia, and metabolic dysfunction. Effective Treatment Strategies for Reducing Cardiovascular Risk A comprehensive approach to obesity treatment can significantly lower cardiovascular risk. Pharmacotherapy plays a critical role in obesity management, particularly for patients at high cardiovascular risk. SGLT2 inhibitors, originally developed for diabetes management, have also shown promise in obesity treatment and cardiovascular protection. These medications offer an innovative approach to obesity and cardiovascular disease management, providing an alternative to or adjunct to traditional lipid-lowering and antihypertensive therapies. The Obesity Medicine Association (OMA) provides a comprehensive Obesity Algorithm® , which outlines individualized treatment strategies, including pharmacologic options tailored to patients with cardiovascular comorbidities. These guidelines reinforce the necessity of an individualized, multidisciplinary approach to obesity management in patients with existing heart disease. Obesity and cardiovascular disease are intricately linked, making obesity management a crucial component of cardiovascular risk reduction. OMA Resources for Clinicians For clinicians seeking to enhance their expertise in obesity and cardiovascular disease management, the Obesity Medicine Association (OMA) offers a variety of resources.
Understanding Leptin Resistance: Symptoms & Treatment Options
Learn about the common symptoms associated with leptin resistance and the best ways to treat patients affected by this issue in our comprehensive guide.
Connecting the Dots: What We Need to Consider When Addressing Obesity
Obesity is a complex, chronic disease that is a major risk factor for other cardiovascular, renal and metabolic conditions, including liver disease and cardiovascular disease. Sandy Sommer, Head of the Therapeutic Area for Cardiovascular, Renal and Metabolic at Boehringer Ingelheim, explains why it is vital that we view obesity and related metabolic conditions through the lens of connectivity.
Lipodystrophy: Types, Causes, Symptoms & Treatment
Deepen your understanding of lipodystrophy—from symptoms and diagnosis to treatment strategies—with our comprehensive guide.
Obesity and Hypertension: Mechanisms, Risks, and Treatment
Hypertension in patients with obesity is on the rise. Learn the key risk factors and how to manage them effectively.
Celebrating 75 Years: A Journey Through the History of the Obesity Medicine Association
Explore the milestones, innovations, and advocacy efforts that have shaped the field, from early beginnings to modern breakthroughs. Join us in honoring the past and advancing the future of obesity medicine.
Obesity and Exercise
Explore the relationship between obesity and exercise, including current guidelines, challenges, and benefits beyond weight loss.
The Vegan Diet and Weight Loss
In the U.S., only about 1% of people follow a strictly vegan diet, according to a 2023 Gallup poll. However, many others say they have considered or tried it or are at least trending away from animal-based foods.
Sarcopenic Obesity: Causes, Diagnosis & Treatment
Explore the emerging health issue of sarcopenic obesity and its impact on aging populations in our comprehensive guide.